Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Applied Therapeutics, Inc. APLT
$1.57
-$0.08 (-4.85%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
96608331.00000000
-
week52high
2.18
-
week52low
0.50
-
Revenue
0
-
P/E TTM
-1
-
Beta
1.85592900
-
EPS
-2.08000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 12:30
Описание компании
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Citigroup | Buy | Buy | 17 авг 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 16 авг 2022 г. |
| Citigroup | Buy | Buy | 20 мая 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 21 мар 2022 г. |
| Barclays | Equal-Weight | Overweight | 04 янв 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Shendelman Shoshana | A | 2715987 | 1964362 | 11 янв 2023 г. |
| Shendelman Shoshana | D | 751625 | 15870 | 11 янв 2023 г. |
| Hansard Adam | A | 392475 | 300000 | 11 янв 2023 г. |
| Hansard Adam | D | 92475 | 4495 | 11 янв 2023 г. |
| Perfetti Riccardo | A | 704856 | 550000 | 11 янв 2023 г. |
| Perfetti Riccardo | D | 154856 | 6053 | 11 янв 2023 г. |
| Ortega Steven A. | A | 55404 | 40000 | 15 ноя 2022 г. |
| Shendelman Shoshana | A | 767495 | 50000 | 14 окт 2022 г. |
| Shendelman Shoshana | A | 717495 | 73256 | 13 окт 2022 г. |
| Shendelman Shoshana | A | 644239 | 38153 | 12 окт 2022 г. |
Новостная лента
7 Hot Growth Stocks Poised to Triple in 2023
InvestorPlace
05 мая 2023 г. в 14:24
Any investor seeking growth stocks that are poised to triple in 2023 will need a strong appetite for risk. That much is very clear.
4 Top Penny Stocks To Buy According To Analysts, Targets Up To 695%
PennyStocks
27 апр 2023 г. в 11:12
Analysts say these could be penny stocks to buy. Do you agree with their outlook?
3 Penny Stocks To Buy According To Analysts, Targets Up To 1,029%
PennyStocks
25 апр 2023 г. в 11:28
Analysts say these are penny stocks to buy but do you agree? The post 3 Penny Stocks To Buy According To Analysts, Targets Up To 1,029% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Applied Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
GlobeNewsWire
01 мар 2023 г. в 07:00
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will participate in a Neuromuscular & Bone Panel at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 2:10 p.m. ET in Boston.
Applied Therapeutics to Present at the SVB Securities Global Biopharma Conference
GlobeNewsWire
09 февр 2023 г. в 07:00
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will present virtually at the SVB Securities Global Biopharma Conference on Thursday, February 16, 2023 at 2:20 p.m. ET.